
Experience
Abivax Announces $235.8 Million IPO
October 20, 2023
Cooley advised Abivax, a clinical-stage biotech company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases, on its $235.8 million initial public offering.
Related contacts
Related Practices & Industries
Hughes & Company Invests in Health Data Innovations
October 2, 2023
Cooley advised Hughes & Company, a private equity firm focused on healthcare software and technology-enabled services, on its strategic investment in Health Data Innovations, a founder-owned healthcare data integration-as-a-service company.
Related contacts
Related Practices & Industries
Definitive Healthcare Acquires Populi
August 14, 2023
Cooley advised Definitive Healthcare, a commercial intelligence company focused on healthcare, on its acquisition of Populi.
Related contacts
Related Practices & Industries
Bridge to Life Sells Certain Assets to TransMedics
August 3, 2023
Cooley advised Bridge to Life, an organ preservation and perfusion technologies supplier, on its sale of certain assets – including its EVOSS heart and lung and LifeCradle heart perfusion assets – to TransMedics.
Related contacts
Related Practices & Industries
Rubicon Technology Partners Closes Strategic Investment in Tacton
August 1, 2023
Cooley advised private equity firm Rubicon Technology Partners on the strategic investment in Tacton, a top software as a service (SaaS) company trusted by global manufacturers.
Related contacts
Related Practices & Industries
Related news and events
Memberships & affiliations
New York State Bar Association
American Bar Association